Raymond N Haddad, Ahmed Adel Hassan, Mahmoud Al Soufi, Mohamed Kasem
{"title":"Acute thrombosis of an atrial flow regulator in a failing Fontan circulation: recanalization and management.","authors":"Raymond N Haddad, Ahmed Adel Hassan, Mahmoud Al Soufi, Mohamed Kasem","doi":"10.1186/s12872-025-04876-5","DOIUrl":null,"url":null,"abstract":"<p><p>We report the case of an 11-year-old boy with situs inversus, interrupted inferior vena cava with azygos continuation, persistent left superior vena cava with absent bridging vein, congenitally corrected transposition of the great arteries, pulmonary atresia, and ventricular septal defect. He underwent a Kawashima shunt at age 1 and fenestrated extracardiac conduit Fontan completion at age 9, delayed due to loss to follow-up while living abroad. Fifteen months post-op, the patient was diagnosed with plastic bronchitis. Cardiac catheterization revealed elevated Fontan pressures and proximal left pulmonary artery stenosis, which was stented (AndraTec 38 mm Optimus-XL). Although fenestration creation was considered, the procedure was initially delayed allowing for a trial of medical management. Four months later, a 6 mm Occlutech atrial flow regulator (AFR) was placed transjugularly, but thrombosis occurred 48 h later. Transjugular catheter-based clot aspiration (Penumbra Lightning<sup>®</sup> 7) and stenting (10/20 mm Cook Formula stent) followed by sequential high-pressure ballooning increased the fenestration diameter, improving symptoms and hemodynamics. He had a favorable recovery with significant improvements and remained stable at 13 weeks of follow-up.</p>","PeriodicalId":9195,"journal":{"name":"BMC Cardiovascular Disorders","volume":"25 1","pages":"432"},"PeriodicalIF":2.3000,"publicationDate":"2025-06-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12135307/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"BMC Cardiovascular Disorders","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1186/s12872-025-04876-5","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0
Abstract
We report the case of an 11-year-old boy with situs inversus, interrupted inferior vena cava with azygos continuation, persistent left superior vena cava with absent bridging vein, congenitally corrected transposition of the great arteries, pulmonary atresia, and ventricular septal defect. He underwent a Kawashima shunt at age 1 and fenestrated extracardiac conduit Fontan completion at age 9, delayed due to loss to follow-up while living abroad. Fifteen months post-op, the patient was diagnosed with plastic bronchitis. Cardiac catheterization revealed elevated Fontan pressures and proximal left pulmonary artery stenosis, which was stented (AndraTec 38 mm Optimus-XL). Although fenestration creation was considered, the procedure was initially delayed allowing for a trial of medical management. Four months later, a 6 mm Occlutech atrial flow regulator (AFR) was placed transjugularly, but thrombosis occurred 48 h later. Transjugular catheter-based clot aspiration (Penumbra Lightning® 7) and stenting (10/20 mm Cook Formula stent) followed by sequential high-pressure ballooning increased the fenestration diameter, improving symptoms and hemodynamics. He had a favorable recovery with significant improvements and remained stable at 13 weeks of follow-up.
我们报告一个11岁男孩的病例,有静脉倒置,下腔静脉中断并奇静脉延续,持续性左上腔静脉伴桥静脉缺失,先天性纠正大动脉转位,肺动脉闭锁和室间隔缺损。他在1岁时接受了川岛分流术,并在9岁时完成了心外导管开窗手术,由于在国外生活期间没有随访而推迟。术后15个月,患者被诊断为可塑性支气管炎。心导管检查显示Fontan压力升高,左肺动脉近端狭窄,支架置入(AndraTec 38 mm Optimus-XL)。虽然考虑了开窗,但该程序最初被推迟,以便进行医疗管理试验。4个月后,经颈静脉放置6 mm Occlutech心房血流调节剂(AFR),但48小时后血栓形成。经颈静脉导管为基础的血栓抽吸(Penumbra Lightning®7)和支架植入术(10/20 mm Cook Formula支架),随后依次进行高压球囊扩张,增加了开窗直径,改善了症状和血流动力学。患者恢复良好,改善显著,随访13周时病情保持稳定。
期刊介绍:
BMC Cardiovascular Disorders is an open access, peer-reviewed journal that considers articles on all aspects of the prevention, diagnosis and management of disorders of the heart and circulatory system, as well as related molecular and cell biology, genetics, pathophysiology, epidemiology, and controlled trials.